India Pesticides Q1 FY27 Preview: Revenue 340-391 Cr

The setup for Q1 FY27 results

India Pesticides Limited is heading into its Q1 FY27 results with a set of street-style estimates anchored to recent FY26 performance. The stock’s current market price (CMP) is cited at ₹159, alongside a 12-month target range of ₹190-211 (Uniresearch estimate). The preview framework referenced in the provided information uses the company’s Q1 FY26 base and applies the most recent year-on-year growth signal from Q4 FY26. Separately, the company has already reported strong FY26 growth, including a sharp rise in full-year profit. For investors, the key is how much of FY26’s momentum carries into the quarter ending June 2026.

FY26 recap: revenue ₹1,078 Cr, profit ₹120 Cr

For FY26, India Pesticides reported a net profit of ₹120 crore, up 45.8% year-on-year. Revenue for the year rose 27.9% to ₹1,078 crore. The performance was attributed in the supplied text to domestic demand and operational efficiencies. These full-year numbers matter because Q1 FY27 expectations are framed on trailing growth signals rather than a one-off quarter. They also provide context on whether FY26 was a broad-based improvement across periods.

Q3 FY26 highlights: revenue ₹229 Cr, PAT ₹23 Cr

The company’s Q3 FY26 performance is described as strong in the provided material. Consolidated revenue reached ₹229 crore, up 31% year-on-year, and net profit came in at ₹23 crore, up 41% year-on-year. For the nine-month period (9M FY26), revenue stood at ₹808 crore, up 28% year-on-year, with net profit of ₹89 crore, up 44% year-on-year. In another FY26 highlight set, Q3 FY26 total revenue is again stated as ₹229 crore versus ₹175 crore in Q3 FY25, with EBITDA at ₹41 crore and an 18% margin (up from 17%). Net profit is stated at ₹23 crore with a PAT margin of 10%.

Q4 FY26 base: income ₹271 Cr, PAT ₹31 Cr

Ahead of Q1 FY27, the most recent reported quarter referenced is Q4 FY26, which is used as a base for estimates. For the quarter ended March 31, 2026, net profit was ₹31 crore versus ₹22 crore in the same quarter of the prior year. Total income for Q4 stood at ₹271 crore versus ₹211 crore in Q4 of the prior year. EBITDA for the quarter increased to ₹46 crore from ₹35 crore year-on-year. The provided table reiterates: Total Income ₹271 crore (up 28.5% YoY), PAT ₹31 crore (up 40.6% YoY), and basic EPS of ₹2.66.

What the quarterly cost and income lines show (June 2025 vs March 2026)

A quarterly table for India Pesticides lists detailed line items for the quarter ended June 2025 and March 2026, along with comparable year-ago data for June 2024. Total revenue is shown at ₹275.18 crore for June 2025 versus ₹266.49 crore for March 2026, with June 2024 at ₹220.36 crore. Operating income is shown at ₹40.03 crore (June 2025) versus ₹36.64 crore (March 2026), compared with ₹23.98 crore in June 2024. Net income is listed at ₹34.91 crore (June 2025) versus ₹30.65 crore (March 2026), against ₹19.48 crore in June 2024. The table also shows operating expenses of ₹235.15 crore (June 2025) and ₹229.85 crore (March 2026). While the table includes percentage comparisons, the key takeaway is that revenue and profit lines were higher than the year-ago quarter shown.

Q1 FY27 estimates: revenue ₹340-391 Cr, PAT ₹43-55 Cr

The Q1 FY27 estimate range in the provided preview is ₹340-391 crore for revenue and ₹43-55 crore for net profit (PAT). The comparison base is explicitly stated as Q1 FY26 actual revenue of ₹284 crore and net profit of ₹35 crore. The implied year-on-year growth rates presented are +28.5% for revenue and +40.7% for PAT. The estimates are described as being built on a trailing-growth framework applied to the Q1 FY26 base, using the most recent year-on-year growth signal from Q4 FY26.

Dates and disclosures cited

The Q1 FY27 results window is indicated as July-August 2026, aligning with the broader NSE and BSE results season for the quarter ending June 2026. Separately, the board meeting date for approving audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 is cited as May 23, 2026. The publication of the extract of audited financial results is referenced as appearing on May 24, 2026 in Financial Express (English) and Jansatta (Hindi), in compliance with SEBI LODR Regulations 30 and 47.

Market view in the preview: CMP and target range

The preview notes India Pesticides CMP at ₹159 and a 12-month target range of ₹190-211. It also provides an estimated Q1 FY27 revenue range of ₹340-391 crore and PAT range of ₹43-55 crore, which frames expectations into the print. These figures, taken together, signal that the preview is focused on continuing growth rather than a flat quarter. However, the ranges also underline uncertainty around the exact pace of growth compared with Q1 FY26.

Background: earlier capacity and historical scale

The provided material also references an earlier period where Q1 FY23 revenue growth was stated at 27.4% year-on-year and mentions a Pretilachlor Technical 2,000 TPA capacity launch in Q1 FY23. Revenue is cited as ₹2,217 million in that period, which equals ₹221.7 crore, alongside EBITDA of ₹590 million (₹59.0 crore) and net profit of ₹411 million (₹41.1 crore). While these are historical datapoints, they help contextualise how the company’s quarterly scale has evolved over time.

What to watch when the Q1 FY27 numbers arrive

When India Pesticides reports Q1 FY27 results in the indicated July-August 2026 window, investors will likely map actual revenue and PAT against the stated estimate ranges. The Q4 FY26 base numbers cited in the preview, particularly total income of ₹271 crore and PAT of ₹31 crore, provide a recent performance reference. The FY26 full-year outcome of ₹1,078 crore revenue and ₹120 crore PAT sets the broader trend line for growth and profitability. Updates on operating efficiency, reflected previously through EBITDA movement and margins in FY26 disclosures, will also remain central to the market’s reading of the print.